Cobalamin (B12) production

Gut bacteria can make vitamin B12 and related compounds, but that doesn't tell you whether you have enough of the vitamin. This stool result describes their genetic capacity to produce it. Most microbial production happens in the colon, beyond the main site where you absorb B12 from food.

Researchers have studied this capacity in constipation, frailty, infant development, and cancer treatment response. It's an exploratory measurement. There is no established healthy target, and studies haven't shown that using this score to choose treatment improves health.

What This Score Reflects

The test uses DNA sequencing of your stool to estimate your gut community's capacity to make B12. A higher result indicates more estimated production capacity. It doesn't establish how actively those genes are being used, how much vitamin bacteria release, or how much you absorb.

Building B12 requires a long series of chemical reactions. Genome surveys suggest that a minority of gut bacteria have the machinery to make it from scratch, while many more can use B12 or related compounds. Some bacteria obtain these compounds from their surroundings or from other microbes. Laboratory experiments have shown that the form available can affect bacterial growth and competition.

The chemical form matters. In a study of stool from 18 adults who weren't taking very high-dose B12 supplements, B12 averaged about 1.4% of the measured B12-related compounds. Most were other forms that don't provide the same vitamin activity in humans. That study measured molecules in stool, a different measurement from this estimate of genetic capacity.

Why Gut Production Doesn't Establish Your B12 Supply

Your main route for absorbing B12 is in the last part of the small intestine. Intrinsic factor is a protein made in your stomach. It binds the vitamin and enables this absorption process. Most gut bacteria live farther downstream in the colon.

A small human tracer study found that some purified B12 delivered directly into the colon could be absorbed. That establishes that colonic absorption is possible, but it doesn't show how much naturally produced microbial B12 reaches your circulation. You can't rely on this stool score to establish that your dietary supply or absorption is adequate.

Location also changes the relationship between bacteria and B12. In small intestinal bacterial overgrowth, bacteria can consume the vitamin before you absorb it and contribute to deficiency. A stool production estimate doesn't diagnose this condition.

Constipation and Frailty in Later Life

In a study of 61 older adults, frail participants with constipation had lower predicted activity in two B12-making pathways than the comparison groups. The researchers identified bacteria using a marker-gene sequencing method and then inferred their likely functions. They didn't directly measure B12 production or sequence all of the community's production genes.

This is related evidence for microbial production capacity, but it isn't a validation of this stool score. The study also captured one point in time, so it couldn't establish whether the microbial differences contributed to constipation and frailty or resulted from them.

Bowel Inflammation

Research in inflammatory bowel disease has found reduced expression of microbial B12-making genes in stool. Gene expression describes how actively genes are being used. The same analysis didn't find a significant difference in the abundance of vitamin-related genes in microbial DNA.

That distinction matters for this test. Reduced gene activity doesn't necessarily mean reduced genetic capacity, so this finding doesn't establish that a lower production score detects bowel inflammation or follows disease activity.

Early Brain Development

A study of 28 Black infants from low-income neighborhoods in Chicago examined microbial DNA in stool alongside developmental assessments. Greater B12-making capacity was associated with better motor scores in both sexes, while several other associations, including cognition and language, were specific to boys. These exploratory findings don't show that changing microbial production improves development or that this score can identify a developmental disorder.

Melanoma Immunotherapy Response

An analysis that pooled published stool microbiome data from several cohorts of people treated with immunotherapy for melanoma found that bacteria associated with treatment response were more likely to carry B12-making genes. This suggests a difference in the metabolic capabilities of the microbial communities. It doesn't establish that this individual score predicts treatment response or that increasing it would improve treatment.

When Results Can Be Misleading

• Capacity and output differ: production genes can be present without being highly active, and related microbial compounds may have different biological effects.
• Stool consistency and timing matter: studies of bacterial abundance show changes within the same person over time. An unusually hard or loose sample can accompany a different microbial profile, although those studies don't establish the variability of this particular score.
• Processing affects the estimate: storage, DNA extraction, sequencing, and computer analysis can change which organisms and genes are detected. Results from different testing systems aren't interchangeable.
• Diet and medication provide context: B12 intake and stimulant use have been associated with differences in microbial production pathways in particular study populations. These associations don't establish that a lower result is harmful.
• A bacterial name doesn't establish its function: closely related species and strains can differ in their ability to make B12. The abundance of one bacterial group can't substitute for an assessment of the community's production capacity.

Your Own B12 Status

Blood testing addresses whether your body has enough B12. Your symptoms, diet, medication use, and history of stomach or intestinal disease help determine which blood tests are useful. A high stool production score doesn't rule out deficiency, and a low score doesn't establish it.